Karolinska Institutet is one of the world's leading medical Universities. Our mission is to contribute to the improvement of human health through research and education. Our research covers the entire medical field, from basic molecular biological research, to clinical epidemiology and nursing science. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. With our close relationship to the clinical world, a well-established infrastructure, a unique innovation system and financial stability, Karolinska Institutet has excellent prerequisites for sustaining high-quality research and education.

MUL is among the largest state-owned medical Universities in Poland. It has reached a leading position in the following research areas: immunology, molecular biology, genetics of homeostasis disorders, oncology, hypertension and endocrinology. Within the last two years, young researchers from MUL were considered leaders in areas such as cardiology, oncology, immunology and dermatology.

At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities.

We see healthcare as a connected whole. Helping people to live healthily and prevent disease. Giving clinicians the tools they need to make a precision diagnosis and deliver personalized treatment. Aiding the patient's recovery at home in the community. All supported by a seamless flow of data.

As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better.

Region Stockholm is one of Europe's largest healthcare providers, offering everything from telephone advice about self-care to advanced specialist care at the university hospital.

Synlab Italia is a national network of laboratories, blood collection points and diagnostic centres to provide a comprehensive service to patients throughout Italy. The network has grown gradually adopting a strategy of regional, respected and reliable laboratories’ acquisition, in which Synlab implements its organizational model in order to standardize performance all over the country and ensure quality and excellence. This unique diagnostic network introduces a new “integrated” approach to medical innovation, prevention and healthcare in Italy, an approach in line with the quality standards of excellence in Europe. Synlab is now the most important "Integrated Diagnostics" group in Italy, and the chosen partner of many patients, specialists and “service” customers for diagnostic services.

As the Immuno Diagnostic experts within Thermo Fisher Scientific, we develop, manufacture and market complete blood test systems to support clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases.

The first university established in the Nordic countries founded in 1477, is an international research university. Uppsala University is ranked #61 in the Academic Ranking of World Universities 2014. World-class research and high at UU benefit society and business on a global level. The University is characterized by diversity and breadth, with international frontline research at nine faculties including 40,000 students, 1,800 teachers and researchers whereof about 670 professors. Comprehensive peer reviews and university rankings consistently show that research at UU is of the highest international standard. Research, education and innovation serve as guiding concepts in connection with cooperation with the business community and society at large